Rabbit anti-Human IL-6 mAb (CAP)

Recombinant IL-6 Protein

Interleukin 6 (IL-6) is also known as HGF, BSF2, HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts, endothelial cells, et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes, atherosclerosis, depression, Alzheimer’s Disease, systemic, lupus erythematosus, prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.

No cross-reactivity in ELISA assay with recombinant
hCntf、hG-CSF、hGM-CSF、hIL-1A、hIL-1B、hIL-2、hIL-3、hIL-4、hIL-6RA、hIL-6RB、hIL-7、hIL-8、hIL-11、hIL-12、hLIF、hOSM、hTNFA、mIL-2、mIL-4、mIL-5、mIL-6、mIL-11、mIL-12

Human IL-6 Sanwich ELISA Immunoassay